Abstract
The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Journal of Pharmacology and Experimental Therapeutics June 1991, 257 (3) 1146-1153;